Close Menu

NEW YORK (GenomeWeb) – Pharmaceutical firm Arcus Biosciences and precision oncology firm Strata Oncology have entered into a clinical development collaboration in which they will use Strata's biomarker technology to identify responders to Arcus' clinical-stage anti-PD-1 antibody AB122 among a variety of tumor types that don't normally show response to such drugs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.